Despite some daunting and very real near-term challenges, there are good reasons to be optimistic for central nervous system (CNS) innovation to fulfil its promise in the medium term.
In this whitepaper, read about the enablers of CNS breakthrough innovation, the latest outlook on the competitive landscape and CNS market opportunity, and take a deep dive into 4 hot areas of cutting-edge innovation – Alzheimer's, Parkinson's, psychedelics and digital therapeutics.
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Access broad and deep neurology expertise to reduce costs, accelerate timelines and manage risk, from clinical trials to evidence generation and beyond.
